Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Non-Small-Cell Lung | 7 | 2024 | 5426 | 0.910 |
Why?
|
Hemostatic Techniques | 1 | 2024 | 116 | 0.870 |
Why?
|
Lung Neoplasms | 9 | 2024 | 13589 | 0.850 |
Why?
|
Suture Techniques | 1 | 2024 | 776 | 0.660 |
Why?
|
Spheroids, Cellular | 1 | 2021 | 332 | 0.640 |
Why?
|
Dendritic Cells | 3 | 2014 | 2753 | 0.620 |
Why?
|
Organophosphorus Compounds | 1 | 2018 | 207 | 0.560 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2019 | 290 | 0.550 |
Why?
|
Carbazoles | 1 | 2018 | 221 | 0.550 |
Why?
|
Neoplasms, Experimental | 1 | 2021 | 1232 | 0.500 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2020 | 451 | 0.490 |
Why?
|
Thyroid Neoplasms | 2 | 2024 | 2360 | 0.450 |
Why?
|
Interleukin-15 | 1 | 2014 | 185 | 0.440 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2847 | 0.350 |
Why?
|
Receptors, IgG | 1 | 2013 | 564 | 0.340 |
Why?
|
Thalidomide | 1 | 2015 | 885 | 0.330 |
Why?
|
Piperidines | 1 | 2018 | 1664 | 0.330 |
Why?
|
Interferons | 1 | 2013 | 714 | 0.330 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2531 | 0.320 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2013 | 246 | 0.320 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3611 | 0.310 |
Why?
|
Cell Communication | 1 | 2014 | 1662 | 0.280 |
Why?
|
Head and Neck Neoplasms | 4 | 2024 | 2915 | 0.270 |
Why?
|
Pyrimidines | 1 | 2018 | 3050 | 0.260 |
Why?
|
Nanoparticles | 2 | 2014 | 1986 | 0.250 |
Why?
|
Vaccines | 1 | 2014 | 845 | 0.250 |
Why?
|
Protein Kinase Inhibitors | 2 | 2020 | 5709 | 0.250 |
Why?
|
Angiogenesis Inhibitors | 1 | 2015 | 2062 | 0.240 |
Why?
|
Immunotherapy | 1 | 2021 | 4728 | 0.240 |
Why?
|
MicroRNAs | 1 | 2021 | 3806 | 0.240 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4083 | 0.230 |
Why?
|
Lymphocyte Activation | 1 | 2014 | 5490 | 0.220 |
Why?
|
T-Lymphocytes | 2 | 2015 | 10269 | 0.170 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2023 | 246 | 0.170 |
Why?
|
Republic of Korea | 1 | 2020 | 587 | 0.150 |
Why?
|
Aged, 80 and over | 5 | 2024 | 59679 | 0.150 |
Why?
|
Exanthema | 1 | 2023 | 504 | 0.150 |
Why?
|
Cisplatin | 1 | 2024 | 1661 | 0.150 |
Why?
|
Survival Rate | 3 | 2021 | 12875 | 0.150 |
Why?
|
Multiple Myeloma | 1 | 2015 | 5193 | 0.140 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2022 | 493 | 0.140 |
Why?
|
Female | 16 | 2024 | 396926 | 0.130 |
Why?
|
Brain Neoplasms | 3 | 2024 | 9177 | 0.130 |
Why?
|
Middle Aged | 13 | 2024 | 223406 | 0.130 |
Why?
|
Pleural Neoplasms | 1 | 2021 | 612 | 0.130 |
Why?
|
Humans | 26 | 2024 | 768369 | 0.130 |
Why?
|
Fatal Outcome | 1 | 2020 | 1841 | 0.120 |
Why?
|
Organ Specificity | 1 | 2020 | 1974 | 0.120 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2021 | 736 | 0.120 |
Why?
|
Aortic Valve | 1 | 2024 | 1967 | 0.120 |
Why?
|
Incidence | 2 | 2024 | 21552 | 0.110 |
Why?
|
Thrombomodulin | 1 | 2014 | 107 | 0.110 |
Why?
|
Aged | 9 | 2024 | 171514 | 0.110 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2930 | 0.100 |
Why?
|
Male | 13 | 2024 | 364761 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3116 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4861 | 0.100 |
Why?
|
Aortic Valve Stenosis | 1 | 2024 | 2031 | 0.100 |
Why?
|
Neoplasms | 1 | 2021 | 22389 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9425 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1943 | 0.100 |
Why?
|
Killer Cells, Natural | 2 | 2024 | 2207 | 0.090 |
Why?
|
NF-kappa B | 1 | 2019 | 2491 | 0.090 |
Why?
|
Lectins, C-Type | 1 | 2014 | 589 | 0.090 |
Why?
|
Prognosis | 5 | 2024 | 30031 | 0.090 |
Why?
|
HIV | 1 | 2018 | 1587 | 0.090 |
Why?
|
Antigen-Presenting Cells | 1 | 2014 | 964 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11844 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 1637 | 0.090 |
Why?
|
Time Factors | 2 | 2024 | 40271 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2021 | 2819 | 0.090 |
Why?
|
Granuloma, Plasma Cell | 1 | 2011 | 80 | 0.090 |
Why?
|
Fibrinolytic Agents | 1 | 2020 | 2082 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2964 | 0.090 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4931 | 0.090 |
Why?
|
Blood Glucose | 1 | 2024 | 6429 | 0.090 |
Why?
|
Signal Transduction | 1 | 2013 | 23639 | 0.090 |
Why?
|
Antigens, Surface | 1 | 2014 | 1615 | 0.090 |
Why?
|
DNA Methylation | 1 | 2024 | 4425 | 0.080 |
Why?
|
Cohort Studies | 3 | 2024 | 41782 | 0.080 |
Why?
|
Mutation | 4 | 2024 | 30235 | 0.080 |
Why?
|
Retrospective Studies | 6 | 2024 | 81835 | 0.080 |
Why?
|
Thrombosis | 2 | 2020 | 2954 | 0.080 |
Why?
|
Interferon-alpha | 1 | 2013 | 909 | 0.080 |
Why?
|
Chemokines | 1 | 2013 | 963 | 0.080 |
Why?
|
Antigen Presentation | 1 | 2014 | 1247 | 0.080 |
Why?
|
Antigens | 1 | 2014 | 1443 | 0.080 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2013 | 672 | 0.080 |
Why?
|
Databases, Factual | 1 | 2024 | 8081 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2562 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2014 | 1615 | 0.070 |
Why?
|
Mice | 3 | 2021 | 82051 | 0.070 |
Why?
|
Adult | 7 | 2024 | 223528 | 0.070 |
Why?
|
Disease Progression | 2 | 2021 | 13643 | 0.070 |
Why?
|
Antibodies | 1 | 2014 | 2426 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1660 | 0.060 |
Why?
|
Risk Assessment | 2 | 2024 | 24310 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6400 | 0.060 |
Why?
|
Palliative Care | 1 | 2021 | 3644 | 0.060 |
Why?
|
Treatment Outcome | 2 | 2024 | 65408 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2818 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4362 | 0.060 |
Why?
|
Animals | 5 | 2021 | 169424 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6537 | 0.060 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 17149 | 0.060 |
Why?
|
Monocytes | 1 | 2013 | 2589 | 0.060 |
Why?
|
Inflammation | 2 | 2020 | 10863 | 0.050 |
Why?
|
Tissue Donors | 1 | 2013 | 2377 | 0.050 |
Why?
|
Liver Diseases | 1 | 2011 | 1307 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 3939 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11139 | 0.050 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2013 | 2173 | 0.040 |
Why?
|
Risk Factors | 2 | 2024 | 74915 | 0.040 |
Why?
|
Patient Advocacy | 1 | 2021 | 362 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2014 | 19035 | 0.040 |
Why?
|
Papillomaviridae | 1 | 2024 | 1135 | 0.040 |
Why?
|
Creatinine | 1 | 2024 | 1915 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2011 | 2775 | 0.040 |
Why?
|
Hemostasis | 1 | 2020 | 470 | 0.040 |
Why?
|
Glycosaminoglycans | 1 | 2020 | 611 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9508 | 0.040 |
Why?
|
Virus Internalization | 1 | 2020 | 501 | 0.030 |
Why?
|
Phenotype | 1 | 2014 | 16712 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 54913 | 0.030 |
Why?
|
Renin-Angiotensin System | 1 | 2020 | 735 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 620 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2020 | 734 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2024 | 6087 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3278 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2072 | 0.030 |
Why?
|
Hexuronic Acids | 1 | 2011 | 145 | 0.020 |
Why?
|
Glucuronic Acid | 1 | 2011 | 150 | 0.020 |
Why?
|
HIV Infections | 1 | 2018 | 17492 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1816 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4613 | 0.020 |
Why?
|
Child, Preschool | 1 | 2013 | 42620 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7245 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8751 | 0.020 |
Why?
|
Alginates | 1 | 2011 | 250 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2024 | 11249 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7213 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8636 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2768 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2020 | 4426 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1881 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3062 | 0.020 |
Why?
|
Young Adult | 1 | 2013 | 60038 | 0.020 |
Why?
|
Elasticity Imaging Techniques | 1 | 2011 | 391 | 0.020 |
Why?
|
Dogs | 1 | 2011 | 3847 | 0.020 |
Why?
|
Child | 1 | 2013 | 80856 | 0.010 |
Why?
|
Adolescent | 1 | 2013 | 89163 | 0.010 |
Why?
|
Anticoagulants | 1 | 2020 | 4835 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 2011 | 1520 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 13065 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26348 | 0.010 |
Why?
|
Swine | 1 | 2011 | 5996 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12242 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39429 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15638 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18390 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20763 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 36840 | 0.000 |
Why?
|
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(81)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_